The OCRC has five major goals:
1. Develop new methods for early detection of ovarian cancer.
2. Develop a comprehensive understanding of ovarian cancer pathogenesis.
3. Characterize the genetic factors that drive the development of hereditary and sporadic forms of ovarian cancer.
4. Develop new approaches to treat and prevent ovarian cancer.
5. Support clinical trials to assess safety and efficacy of new treatments.
The ultimate goal of these programs is to improve the quality of life for women with ovarian cancer and provide guidance and support to their families.
Patient care and clinical trials are conducted in the Jordan Center for Gynecologic Cancer in the Perelman Center for Advanced Medicine. Our translational and basic research program is located in the Smilow Center for Translational Research, immediately adjacent to the Perelman Center, and in the Biomedical Research Building. These state of the art facilities encourage our "bench to bedside" approach to ovarian cancer and support our multidisciplinary approach to patient care and research.